Disposal practices for unused medications in New Zealand community pharmacies

Journal of Primary Health Care

Volumn 3, Issue 3, 2011, Pages 197-203

  Tong, Alfred Y C ^a   Peake, Barrie M ^b   Braund, Rhiannon ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Community pharmacist; Environment; Excess medication; Medication disposal; Pharmaceutical waste

Indexed keywords

DRUG;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEW ZEALAND; PHARMACIST; POLLUTION; QUESTIONNAIRE; WASTE DISPOSAL;

ADULT; AGED; AGED, 80 AND OVER; ENVIRONMENTAL POLLUTION; FEMALE; HUMANS; MALE; MEDICAL WASTE DISPOSAL; MIDDLE AGED; NEW ZEALAND; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; QUESTIONNAIRES;

EID: 84855407470     PISSN: 11726164     EISSN: 11726156     Source Type: Journal    
DOI: 10.1071/hc11197     Document Type: Article

References (30)

1. Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents for subtle change? Environ Health Perspect. 1999;107:907-38.
2. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zuagg SD, Barber LB, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in USstreams, 1999-2000: a national reconnaissance. Environ Sci Tech. 2002;36:1202-11.
3. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature. 2004;427:630-3.
4. Lange R, Hutchinson TH, Croudace CP, Siegmund F. Effects of the synthetic estrogen 17-alpha-ethinylestradiol on the lifecycle of the fathead minnow (Pimephales promelas). Environ Toxicol Chem. 2001;20:1216-27.
5. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 2006;40(17):3297-303.
6. Chang H, Hu H, Shao B. Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters. Environ Sci Technol. 2007;41:3462-8.
7. Zorita S, Martensson L, Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci Total Environ. 2009;407:2760-70.
8. Comeau F, Surette C, Brun GL, Losier R. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. Sci Total Environ. 2008;396(2-3):132-46.
9. Tixier C, Singer HP, Oellers S, Muller SR. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen and naproxen in surface waters. Environ Sci Technol. 2003;37(6):1061-8.
10. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res. 2008;42(13):3498-518.
11. Bartlett-Hunt SL, Snow DD, Damon T, Shockley J, Hoagland K. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska. Environ Pollut. 2009;157:786-91.
12. Rabiet M, Togola A, Brissaud F, Seidel JL, Budzinski H, Elbaz-Poulichet F. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ Sci Technol. 2006;40(17):5282-8.
13. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA. Pharmaceuticals and endocrine disrupting compounds in USdrinking water. Environ Sci Technol. 2009;43(3):597-603.
14. Guo YC, Krasner SW. Occurence of primidone, carbamazepine, caffeine, and precursors from N-nitrosodimethylamine in drinking water sources impacted by wastewater. J Am Water Resour Associ. 2009;45(1):58-67.
15. Gotz K, Keil F. Drug disposal in private households: does the disposal of pharmaceuticals via domestic sanitary devices contribute to water contamination? Z Umweltchem Okotox. 2007;19(3):180-8.
16. Abahussain EA, Ball DE. Disposal of unwanted medicines from households in Kuwait. Pharm World Sci. 2007;29(4):368-73.
17. Gehler Mariacher G, Rota M, Hersberger KE. Return of unused drugs to pharmacies. Praxis (Bern 1994). 1998;87(43):1441-3.
18. Kotchen M, Kallaos J, Wheeler K, Wong C, Zahller M. Pharmaceuticals in wastewater: behavior, preferences, and willingness to pay for a disposal program. J Environ Manage. 2009;90(3):1476-82.
19. Persson M, Sabelstrom E, Gunnarsson B. Handling of unused prescription drugs-knowledge, behaviour and attitude among Swedish people. Environ Int. 2009;35(5):771-4.
20. Seehusen DA, Edwards J. Patient practices and beliefs concerning disposal of medications. J Am Board Fam Med. 2006;19(6):542-7.
21. Glassmeyer ST, Hinchey EK, Boehme SE, Daughton CG, Ruhoy IS, Conerly O, et al. Disposal practices for unwanted residential medications in the United States. Environ Int. 2009;35(3):566-72.
22. Kuspis DA, Krenzelok EP. What happens to expired medications? A survey of community medication disposal. Vet Hum Toxicol. 1996;38(1):48-9.
23. Jarvis CL, Seed SM, Silva M, Sullivan KM. Educational campaign for proper medication disposal. J Am Pharm Assoc. 2009;49(1):65-8.
24. Tong AYC, Peake BM, Braund R. Disposal practices for unused medications around the world. Environ Int. 2011;37(1):292-8.
25. Braund R, Yuen Y-C, Jung J. Identification and quantification of medication returned to Otago pharmacies. NZ Fam Phys. 2007;34(4):258-62.
26. Braund R, Chuah F, Gilbert R, Gn G, Soh A, Tan LY, et al. Identification of the reasons for medication returns. NZ Fam Phys. 2008;35(4):248-52.
27. Braund R, Peake BM, Shieffelbien L. Disposal practices for unused medications in New Zealand. Environ Int. 2009;35(6):952-5.
28. James TH, Helms ML, Braund R. Analysis of medications returned to community pharmacies. Ann Pharmacother. 2009;43(10):1631-5.
29. Leclercq M, Mathieu O, Gomez E, Casellas C, Fenet H, Hillaire-Buys D. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants. Arch Environ Contam Toxicol. 2008;56(3):408-15.
30. Postigo C, de Alda MJL, Barcelo D. Drugs of abuse and their metabolites in the Ebro River basin: occurrence in sewage and surface water, sewage treatment plants removal efficiency, and collective drug usage estimation. Environ Int. 2010;36(1):75-84.